Analytical Data
-
基因名
ZPR1
- Application
-
别名
(Zinc finger protein 259)
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O75312
-
表达区间
1-459aa
-
分子量
58.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZPR1, or zinc-binding protein 1, is a vital protein involved in various cellular processes, including cell growth, differentiation, and apoptosis. It serves as a crucial regulator of cellular signaling pathways by modulating the availability of zinc ions, which are essential cofactors for numerous enzymes and cellular functions. Research on ZPR1 has gained momentum due to its implications in different biological contexts, such as tumorigenesis and neurodegenerative diseases. The ability of ZPR1 to bind zinc has attracted interest for its potential therapeutic applications, as manipulating its expression or activity may provide novel strategies for disease intervention. Moreover, studies have revealed that alterations in ZPR1 expression are associated with pathological conditions, heightening the need for detailed understanding of its functional mechanisms. As a result, the recombinant expression of ZPR1 in various systems allows for in-depth investigation into its structural properties, binding affinities, and interactions with other cellular components. Furthermore, developing ZPR1 as a recombinantly produced protein can facilitate high-throughput screening for potential drugs targeting zinc-dependent pathways, thus advancing both basic research and clinical applications. Overall, the study of ZPR1 and its recombinant forms represents a promising frontier in elucidating the roles of zinc in health and disease, pushing the boundaries of our understanding in molecular biology and therapeutic innovation.












